was added and heated to reflux for 2-3 h. Water (25 mL) was added into the solution.
The mixture was then acidified with acetic acid to pH≈5 and kept for 30 min under 0 ℃ to give yellow precipitate. After removing the solvent, the precipitate was washed with water to afford 2-methyl-4-(pyridin-2-yl)pyrimidine hydrosulfide (2). Preparation of 2-(methylsulfonyl)-4-(pyridin-3-yl)pyrimidine (4). Compound 3 (9.81 g, 45 mmol) was dissolved in 45 mL acetone and heated to reflux for 30 min, and Na 2 WO 4 (0.91 g) was added. After stirring for 10 min, H 2 O 2 (12.34 g, 89 mmol) was added dropwise within 30 min. The solution was heated to reflux for 3-5 h, after which insoluble solid was formed. Na 2 S 2 O 3 (4.5 g) dissolved in 100 mL was added to the mixture with stirring, and kept for 30 min at 0-5 ℃. After removing the solvent, the residue was dried at 60 ℃ to afford 4 (8.5 g, purity > 95%, yield 80% The pH of the reaction solution was then adjusted with 300 mL 3N HCl to 5~6, followed by adding 200 mL ice-water, and stirred for 30 min at RT. After removing the solvent, the light yellow solid was dried to give compound 6 (32.17 g, purity > 95%, yield 80% 
Preparation of tert-butyl (4-methyl-3-((4-
(
Preparation of 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)oxy)aniline (7).
Compound 6 (32.17 g, 85 mmol) was dissolved in 130 mL dichloromethane (DCM), in which 100 g trifluoroacetate was added at 0 ℃. The solution was heated to reflux for 2-3 h, and then pH was adjusted to 8-9 with 10% NaOH. The organic phase was washed with water, and DCM was removed by evaporation. The residue was treated with 50 mL ethanol for 1 h, filtered and dried to afford yellow solid 7 (23.7 g, purity > 98%, yield 95% 
Preparation of 3-(chloromethyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin -2-yl)-oxy)phenyl)-benzamide (8).
3-(Chloromethyl)benzoic acid (12.6 g, 74 mmol)
and EDCl (17 g, 89 mmol) were dissolved in 110 mL DCM, followed by adding 13.7 g compound 7 at 10 ℃, and heated to reflux for 1-2 h. The solution was washed successively with 250 mL water and NaHCO 3 . After removing the organic phase, the yellow solid 8 was obtained (12.5 g, purity > 95%, yield 59%).
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Preparation of N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)oxy)phenyl)-3-((4-methylpiperazin-1-yl)methyl)benzamide hydrochloride (TGI1002).
Compound 8 (12.4 g, 28 mmol), 1-methylpiperazine (3.45 g, 34 mmol) and ET 3 N (1.74 mL, 17 mmol) were added to 75 mL of DCM and stirred for 15 h at RT. The organic phase was collected, dried and filtered to give 9. Compound 9 was then purified by column chromatograph (chloroform/methanol=20/1). Purified 9 (2 g) was dissolved in 5 mL methanol containing 10% HCl, and TGI1002 was then obtained as a yellow powder after removing the solvent. The total yield of TGI1002 was 60% and the purity was > 99% by HPLC analysis. 4, 162.4, 160.0, 159.0, 148.4, 142.7, 141.2, 138.6, 134.4, 133.2, 133.1, 132.9, 130.0, 128.5, 128.2, 127.5, 126.5, 125.9, 125.7, 117.5, 113.3, 111.6, 58.1, 48.4, 46.5, 41.1, 13.1; IR (KBr) γ 3408.0, 3061.2, 2927 .4, 2644 .3, 2562 .0, 1635 .8, 1582 .6, 1566 .9, 1505 .9, 1454 .9, 1385 .8, 1284 .9, 1263 .0, 1207 .7, 1095 .3, 1012 .6 cm -1 .
9
Preparation of N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)oxy)phenyl)-3-(piperazin-1-yl-methyl)benzamide (10). Synthesis and purification of compound 10 was performed with the same procedures as compound 9 except using piperazine to replace 1-methyl-piperazine. 6, 167.0, 165.0, 164.4, 163.8, 153.0, 147.7, 145.4, 143.1, 138.8, 137.9, 137.6, 137.5, 134.5, 133.0, 132.6, 132.0, 130.8, 130.7, 130.4, 122.6, 118.3, 116.2, 62.9, 50.7, 43.3, 17.5; IR (KBr) γ 3407.8, 2928 .6, 2709 .7, 2571 .8, 1661 .5, 1634 .4, 1584 .3, 1567 .5, 1506 .4, 1445 .7, 1387 .0, 1286 .7, 1262 .3, 1211 .2, 1162 .7, 1095 .3, 1013 .7 cm -1 . 3-((4-methyl-3-((4-(pyridin-3-yl) pyrimidin-2-yl)oxy) -phenyl)carbamoyl)benzyl)piperazin-1-yl)acetic acid (TGI1002-COOH).
Preparation of 2-(4-(
TGI1002-COOH was synthesized from compound 10 based on previous report (1). 162.8, 161.2, 151.3, 147.5, 144.9, 143.0, 138.3, 138.0, 135.5, 135.2, 133.2, 131.9, 129.3, 128.9, 128.2, 127.2, 126.2, 118.8, 114.8, 114.0, 63.5, 61.7, 49.8, 43.7, 16.0; IR (KBr) γ 3443.7, 2961 .7, 2823 .0, 1590 .8, 1383 .1, 1352 .8, 1288 .3, 1206 .2, 1125 .8, 1099 .2, 1002 .4 cm -1 . 
